CIBC Bancorp USA »

Lineage Cell Therapeutics In shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2026-06-30 $13k 10k 1.31

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Flutter Entmt SHS (FLUT)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Micron Technology (MU)
Draftkings Com Cl A (DKNG)

View all positions for CIBC Bancorp USA

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
Morgan Stanley
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
State Street Corporation

View all funds holding Lineage Cell Therapeutics In